南京 [切换城市] 南京招聘南京科研人员招聘

有机合成研发员(职位编号：NJ-001)

南京马龙医药研发有限公司

  • 公司规模：少于50人
  • 公司性质：外资(非欧美)
  • 公司行业：制药/生物工程  学术/科研

职位信息

  • 发布日期：2014-07-16
  • 工作地点：南京-浦口区
  • 招聘人数：3
  • 工作经验：一年以上
  • 学历要求：硕士
  • 语言要求：英语熟练
  • 职位类别：科研人员  化工实验室研究员/技术员

职位描述

本职位工作地点：南京浦口区
职位要求：
1、有机化学或相关专业硕士，具有有机合成或药物化学工作经验者优先
2、热爱有机合成，对合成研发有浓厚的兴趣。
3、有较强的理论基础和实际操作能力。
4、熟练阅读文献(英文)和利用文献的能力。
5、很强的工艺执行力和发现问题的能力。
6、认可公司价值观，为人诚实正直，强烈的责任心和团队合作意识。
7、具有良好的沟通能力(有良好的英语和计算机操作水平)和强烈的学习愿望
8、工作积极，乐观向上，善于自我激励和承受压力

岗位职责：
1、精细周到的试验設计,
2、准确无误的试验记录
3、有机小分子的合成与制备
4、及时完整的研究报告总结，积极讨论，按照计划按时完成项目
5、工艺路线的优化改进及产品质量改进

注：所有应聘人员请务必附“工作总结”或“研究总结”一份。


Lab Assistant
Main Purpose
· The incumbent is to support application/product development for Mapi in China
Major Accountabilities:
· Conduct material characterization and lab experiments in support of application/product development
· Participate in development of new product or product modification
· Deliver experimental results in a timely and effective way, with high quality
· Participate in equipment and lab daily maintenance
Skills & Qualifications:
· Master's degree in organic chemistry science or related field with a year of industry working experience
· Self motivated with strong desire to learn and to deliver; well-organized
· Good problem solving skills and good communication skills; a team player
· Good language skills in both English and Chinese; speaking, reading and writing.


我们为员工提供：

1、完善的福利保障制度，包括五险一金的缴纳，带薪年假，每年体检、旅游等

2、丰厚的奖金制度，只要你肯努力，就能挑战高薪

3、公司为外地员工免费提供食宿，南京本地员工提供班车接送。

公司介绍

MAPI Pharma Group is a new multi national company in Israel, Germany, HK and China, and is developing a unique and novel way of tapping the API (Active Pharmaceutical Ingredient) market for Generic Pharmaceuticals, and then develops the most effective route of production, and physical form of the API production will be done in new plants in China and Germany.

MAPI Pharma Group will be one of the leading players in the API markets. Using its excellent networking in these territories, MAPI will provide generic intermediates & API's and in parallel will develop finish dosage forms either to MAPI's API's, as a vertically integrated company and generic to other leading brands. These dosage forms might be simple or complex generics like controlled release. At the beginning, MAPI will focus on intermediates & API's forms which represent about 80% of the pharmaceutical market as well as intermediate API for pharmaceuticals.

The Company will develop more than 20 new advanced generic Intermediates and API's for which their patents will expire till 2020, and also will develop new patents, as well as at an estimated rate of 2-3 new molecules per annum.